Shingles vaccine
Zostavax, Shingrix
Begutachtet von Sid DajaniZuletzt aktualisiert von Michael Stewart, MRPharmSZuletzt aktualisiert am 12. September 2022
Erfüllt die Anforderungen des Patienten redaktionelle Richtlinien
- HerunterladenHerunterladen
- Teilen Sie
Teilen Sie
Zostavax® or Shingrix® are given as part of a vaccine immunisation programme to protect against shingles.
The vaccine will be injected under your skin or into the muscle of your upper arm.
Die häufigsten Nebenwirkungen sind ein Spannungsgefühl an der Injektionsstelle und Kopfschmerzen. Diese sollten bald abklingen.
In diesem Artikel:
Lesen Sie unten weiter
About shingles vaccine
Art des Arzneimittels | Herpes zoster vaccine |
Verwendet für | Prevention of shingles (herpes zoster) in people over 50 years of age and people over the age of 18 at higher risk of developing shingles |
Auch genannt | Zostavax®, Shingrix® |
Verfügbar als | Subcutaneous or intramuscular injection |
Shingles is an infection of a nerve and the area of skin supplied by the nerve. It is caused by a virus called the varicella-zoster virus (this is the same virus that causes chickenpox). Shingles is sometimes called herpes zoster. The symptoms of shingles are a skin rash, blisters and pain. These occur in the areas of skin that the infected nerves supply. The pain may continue even after the rash and skin blisters have healed.
Shingles can occur at any age, but it is most common in people over the age of 50 years. A vaccine against the varicella-zoster virus has been shown to be effective in reducing the risk of older people developing shingles. In the UK from September 2013, a shingles vaccine immunisation programme was introduced for people aged 70 years to protect against herpes zoster. There is also a catch-up programme which offers the vaccine to anyone aged between 70 and 79 years who may have previously missed out on immunisation.
Zostavax® is a live vaccine which contains a weakened form of the varicella-zoster virus. Because of this it is not suitable for people with a weakened immune system. An inactivated vaccine called Shingrix®, which does not contain live virus, is now available for people with a weakened immune system.
From 1st September 2023 everyone who is eligible for vaccination under the UK iimmunisation programme will receive two doses of Shingrix® vacccine, once central stocks of Zostavax® have been used up.
Before having shingles vaccine
Some medicines are not suitable for people with certain conditions, and sometimes a medicine may only be used if extra care is taken. For these reasons, before having shingles vaccine make sure your doctor or pharmacist knows:
Wenn Sie sich unwohl fühlen oder hohes Fieber haben.
If you have been told you have a weakened immune system. This may be a result of an illness or taking other medicines.
Wenn Sie schon einmal eine allergische Reaktion auf ein Arzneimittel hatten.
Wenn Sie andere Arzneimittel einnehmen. Dazu gehören alle Arzneimittel, die Sie einnehmen und die rezeptfrei erhältlich sind, sowie pflanzliche und ergänzende Arzneimittel.
If you could be pregnant or are planning to become pregnant.
Lesen Sie unten weiter
How shingles vaccine is given
Before you are given this treatment, ask to read the manufacturer's printed information leaflet from inside the pack. The leaflet will give you more information about the vaccine and a full list of side-effects which you may experience from having it.
You will be given two doses of Shingrix® vaccine by your doctor or nurse. They will be given between eight weeks and 12 months apart, depending on your immune status. The vaccine is injected just underneath your skin or into a muscle, usually in your upper arm.
If Zostavax® is used to vaccinate against shingles, only one dose is needed.
Can shingles vaccine cause problems?
Along with their useful effects, all medicines can cause unwanted side-effects although not everyone experiences them. Speak with your doctor or pharmacist if any of the following side-effects continue or become troublesome.
Very common Zostavax® side-effects (these affect more than 1 in 10 people) | Was kann ich tun, wenn mir das passiert? |
Pain, redness, swelling, or itching at the site of the injection | Das sollte bald vorbei sein |
Common Zostavax® side-effects (these affect fewer than 1 in 10 people) |
|
Headache, joint pain or muscle pain | Drink plenty of water. If troublesome, take a dose of a suitable painkiller |
High temperature (fever), skin rash | Drink plenty of water and ask a pharmacist to recommend suitable remedies. Talk to your doctor if you develop a blistering rash |
Very common Shingrix® side-effects (these affect more than 1 in 10 people) | Was kann ich tun, wenn mir das passiert? |
Pain, redness, swelling, or itching at the site of the injection | Das sollte bald vorbei sein |
Feeling sick (nausea), being sick (vomiting), diarrhoea, tummy (abdominal) pain | Stick to simple meals - avoid spicy foods. Drink plenty of water to replace lost fluids |
Headache, a high temperature (fever), chills, tiredness, muscle pain | Drink plenty of water. If troublesome, take a dose of a suitable painkiller |
Important: Zostavax® is a live vaccine, which means that a small amount of live virus could be present in your body and be passed on to other people. This is especially true if you develop a blistering rash within four to six weeks of having the vaccine. Try to keep away from pregnant women and people who you know are at risk from infection, especially if you develop blisters.
If you experience any other symptoms which you think may be due to this vaccine, speak with your doctor or pharmacist.
Lesen Sie unten weiter
How to store shingles vaccine
Es ist unwahrscheinlich, dass Sie aufgefordert werden, den Impfstoff zu lagern, bevor er Ihnen verabreicht wird. Sollte dies dennoch der Fall sein, bewahren Sie ihn kühl auf, bis er benötigt wird.
Bewahren Sie alle Arzneimittel außerhalb der Reichweite und Sichtweite von Kindern auf.
An einem kühlen, trockenen Ort aufbewahren, vor direkter Hitze und Licht schützen.
Wichtige Informationen über alle Arzneimittel
Wichtige Informationen über alle Arzneimittel
Wenn Sie sich einer Operation oder einer zahnärztlichen Behandlung unterziehen müssen, teilen Sie der behandelnden Person mit, welche Arzneimittel Sie einnehmen.
If you have any questions about this medicine ask your doctor or nurse.
Nebenwirkungen eines Medikaments oder Impfstoffs melden
Wenn Sie Nebenwirkungen feststellen, können Sie diese online über die Website der Gelben Karte melden.
Weiterführende Literatur und Referenzen
- Manufacturer's PIL, Zostavax®Merck Sharp and Dohme Limited, Das elektronische Arzneimittelkompendium. Stand: Juli 2022.
- Medicines Complete BNF 89th EditionBritish Medical Association und Royal Pharmaceutical Society of Great Britain, London.
- Manufacturer's PIL, Shingrix® powder and suspension for injection, Herpes zoster vaccine (recombinant, adjuvanted); GlaxoSmithKline UK Ltd, The electronic Medicines Compendium. Dated September 2021.
Lesen Sie unten weiter
Artikel Geschichte
Die Informationen auf dieser Seite wurden von qualifizierten Klinikern verfasst und von Fachleuten geprüft.
Nächste Überprüfung fällig: 11. März 2027
12 Sept 2022 | Neueste Version
11 May 2013 | Originally published
Verfasst von:
Helen Allen, MPharm

Fragen, teilen, verbinden.
Stöbern Sie in Diskussionen, stellen Sie Fragen, und tauschen Sie Erfahrungen zu Hunderten von Gesundheitsthemen aus.

Fühlen Sie sich unwohl?
Beurteilen Sie Ihre Symptome online und kostenlos